Valeant Drops After Report Salix Sale Discussions Broke Down

Source: Bloomberg

Thursday, December 01, 2016 | Acquisitions/Mergers , Valeant


Valeant Pharmaceuticals International Inc. dropped after a report that discussions to sell its gastrointestinal drugs unit to Japan’s Takeda Pharmaceutical Co. for about $10 billion have fallen apart. Although the talks could still resume, Valeant is now focused on building the business, called Salix, rather than divesting it, Dow Jones reported, citing unidentified people familiar with the matter.

Open in New Window

Comments

You must be logged in to leave a comment.